Baldrige Metrics
(Health Care, Education, Business, and
Not For Profit Criteria versions available)
Organizations using the Baldrige Criteria often struggle to obtain the best performance metrics to drive improvement. The sample of organizational performance metrics below was derived from hundreds of assessments of organizations using the Baldrige Criteria worldwide. These metrics should be viewed as a menu that you can compare to your existing metrics and get ideas for potential additions and/or substitutions. The metrics are provided in a generic format and usually need to be adapted to your organizations' specific terminology needs.
Sample of Baldrige Health Care Criteria Performance Metrics for Item 7.1 (Health Care Outcomes and Service Delivery Results)
|
1 Mortality rates* |
69 Lung cancer survival rate over time* |
|
2 Morbidity rates |
70 Pressure ulcers-percent of ADC* |
|
2 Medical mortality rate* |
71 Knee replacement patients discharged home after surgery (%) |
|
3 JCAHO Core Measures-CHF (% patients)* |
72 Hip replacement patients-return to unassisted ambulation (days) |
|
4 Percent of CHF patients receiving weighing instructions* |
73 Outpatient Radiology cycle time-from when test was performed to when it was delivered to physician |
|
5 Percent of CHF patients on Coumadin* |
74 C-Section rate (% of total deliveries in comparison to safe rate) |
|
6 CHF patients treated with lipid lowering agents (LLAs)* |
75 Mammography rate (% women 40 and older with biannual mammograms) |
|
7 CHF readmissions (rate) within 31 days* |
76 PAP screening rate (% of women 18 and older screened within three years) |
|
8 CHF mortality rate* |
77 Patient falls (falls per 1,000 days)* |
|
9 CHF treatment indicators (% compliance)* |
78 Percent of complete medication sheets at time of discharge |
|
10 CHF-LFEV assessment (%)* |
79 NPSG-RVVO |
|
11 CHF-ACEI for LVSD* |
80 NPSG-use of high risk abbreviations (rate) |
|
12 Percent of CHF patients following clinical pathways |
81 Percent of prescriptions with dangerous abbreviations* |
|
13 CHF treatment-angiotensin Rx (%) |
82 Medication errors that did not reach the patient as a percent of total medications dispensed* |
|
14 Heart failure-discharge instructions provided (%) |
83 Medication event rate per 10,000 doses dispensed* |
|
15 Heart failure-LVF assessment (patients) |
84 Effectiveness of safety steps and safeguards (reports/1,000 patients)* |
|
16 AMI-beta blockers on arrival (%)* |
85 Percent of nursing home physical restraints used* |
|
17 AMI-ASA at arrival (%)* |
86 Percent compliance with restraint usage policy* |
|
18 AMI-smoking cessation counseling (%)* |
87 Use of restraints (restraints per 1,000 patient days)* |
|
19 AMI infection rate* |
88 Patient Falls Rate (falls per 1,000 patient days) |
|
20 AMI treatment indicators (% compliance)* |
89 Comparative health care outcomes and service delivery results |
|
21 AMI-ASA at discharge (%)* |
90 Unplanned readmissions within __ days* |
|
22 AMI-Beta blocker at discharge (%)* |
91 Home care patients that needed to be admitted (%) |
|
23 AMI-(heart attack)-ACEI for LVS* |
92 Rates of seclusion for behavioral medicine patients* |
|
24 AMI (heart attack)-aspirin given at time of arrival |
93 Seclusion (events per 1,000 discharges) |
|
25 AMI (heart attack)-aspirin given at time of discharge |
94 Rates of restraints for behavioral medicine patients (%)* |
|
26 AMI (heart attack)-smoking cessation (number of patients) |
95 Patients referred to Memory Loss Clinic after Alzheimer's diagnosis (%) |
|
27 Ischemic heart disease patients discharged on aspirin/antiplatelet medicines* |
96 CARE overall score* |
|
28 JCAHO Core Measures-Community Acquired Pneumonia (%)* |
97 Hospitalists significantly impact ALOS-ALOS across high volume DRGs* |
|
29 PneuPonia-ABX within 4 hours of arrival* |
98 Hospitalists mitigate costs of inpatient care-variable cost per case* |
|
30 Community acquired pneumonia-blood cultures obtained* |
99 Open heart program-elective CABG* |
|
31 Pneumonia-median time to ATB (minutes) |
100 Scores on standardized health care proficiency tests |
|
32 Pneumococcal screen/vaccination (patients)* |
101 Patient and other customer treatment/service effectiveness perception determined from related questions in internal surveys |
|
33 Pneumonia-oxygenation assessment* |
102 Patient and other customer treatment/service effectiveness perception from related questions in external surveys |
|
34 Pneumonia-patient screened for flu vaccine (%) |
103 Passing rates on exams required to obtain licenses or certification |
|
35 Pneumonia-blood cultures taken prior to antibiotics given (patients) |
104 Attainment, accreditation of competencies |
|
36 Pneumonia- timely antibiotics given (%) |
105 Other health care outcomes and service delivery failure rates |
|
37 Pneumonia-smoking cessation (patients) |
106 Other health care outcomes and service delivery failure severity |
|
38 VAP rate per 1,000 ventilator days |
107 Other health care outcomes and service delivery failure duration |
|
39 Rate of ventilator-related pneumonia for ICCU* |
108 Health care outcomes and service delivery failure costs |
|
40 Rate of ventilator-related pneumonia for SINU* |
109 Accreditation score* |
|
41 Pneumonia mortality rates* |
110 Accreditation and/or certification achievements |
|
42 Percent of Pneumonia patients using clinical pathways |
111 Patient and other customer support center and/or help desk effectiveness |
|
43 Intensive care unit central line-associated bacteremia rates |
112 Information from external sources (e.g., employers) |
|
44 Surgical mortality rate* |
113 Health care outcomes and treatment/service delivery measures performance in relation to competitors |
|
45 SIP-antibiotic given within one hour of incision |
114 Health care industry performance statistics |
|
46 SIP-antibiotic select for surgery |
115 Health care professional organizations research findings |
|
47 SIP-antibiotic discontinued less than 24 hours after surgery |
116 External assessment of services |
|
48 Surgical verification of ‘right patient’ - percent compliance |
117 Independent agency assessments/reviews |
|
49 Surgical verification of ‘correct procedure’ - percent compliance |
118 Relative performance of departments |
|
50 Surgical verification of ‘correct site’ - percent compliance |
119 Relative performance of branches or related facilities (as appropriate) |
|
51 Surgical verification of ‘correct documentation’ - percent compliance |
120 Performance in relation to health care industry |
|
52 Central line-related blood stream infections for SINU* |
121 Reputation leadership |
|
53 VHA surgical infection project (CABG/Cardiac)-antibiotics received within one hour of incision* |
122 Professional organization recognition and/or awards |
|
54 VHA surgical infection project (Hip/Knee Arthopasty)-antibiotics received within one hour of incision* |
123 Related health care outcomes and service delivery measures from your organization’s list of knowledge assets |
|
55 Catheter-related UTI for SINU* |
124 Benchmark/comparison data available for any of the above or other related results measures |
|
56 Stroke treatment-antiplatelet Rx |
125 Health care field leadership awards and/or recognition |
|
57 Stroke treatment-anticoagulation with atrial fibrillation (%) |
126 Award-Women’s heart/best __ in nation* |
|
58 Stroke mortality rate* |
127 Award-best place to work for information services* |
|
59 Percent patients diagnosed with Ischemic stroke receiving tPA* |
128 Award-best hospital in areas served* |
|
60 Patients with complete recovery or require minimal assistance (%) |
129 Award-best hospital in state* |
|
61 Arthoscopy-average number of days to full ambulation without assistance following arthoscopic surgery |
130 Award-consumer preference award* |
|
62 Trauma-average number of months to return to pre-injury occupational status for major trauma patients |
132 Award-__ best hospital in nation* |
|
63 Trauma-patients whose pain was self-characterized as well-controlled (%) |
132 Award-ASHP Best Practices Award in health system pharmacy* |
|
64 Oncology-patients whose pain was self-characterized as well-controlled (%) |
133 Inpatient length of stay |
|
65 Adverse drug events (number) |
134 Percent ER readmissions within 72 hours |
|
66 Potential adverse drug events intercepted before incident led to complication (number) |
135 Percent increase in number of patient safety (incidents and/or errors) reported from year to year |
|
67 Adverse drug events that prolonged hospitalization (number) |
136 Savings from real-time education of medical staff and intervention at the point of care to ensure correct clinical documentation |
|
68 Nosocomial infection rates |
Thousands more metrics are available |
|
Key: AMI-acute myocardial infarction; CHF - congestive heart failure; LVEF - left ventricular ejection fraction |
|
Note: The metrics information is intentionally incomplete in this sample
Ordering information:
Call 1 425 444 4386 or email: tqi@msn.com to order or obtain additional information